Correlation Between Dupont De and BioAffinity Technologies
Can any of the company-specific risk be diversified away by investing in both Dupont De and BioAffinity Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and BioAffinity Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and bioAffinity Technologies Warrant, you can compare the effects of market volatilities on Dupont De and BioAffinity Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of BioAffinity Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and BioAffinity Technologies.
Diversification Opportunities for Dupont De and BioAffinity Technologies
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Dupont and BioAffinity is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and bioAffinity Technologies Warra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioAffinity Technologies and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with BioAffinity Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioAffinity Technologies has no effect on the direction of Dupont De i.e., Dupont De and BioAffinity Technologies go up and down completely randomly.
Pair Corralation between Dupont De and BioAffinity Technologies
Allowing for the 90-day total investment horizon Dupont De is expected to generate 17.05 times less return on investment than BioAffinity Technologies. But when comparing it to its historical volatility, Dupont De Nemours is 11.63 times less risky than BioAffinity Technologies. It trades about 0.01 of its potential returns per unit of risk. bioAffinity Technologies Warrant is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 78.00 in bioAffinity Technologies Warrant on August 29, 2024 and sell it today you would lose (18.00) from holding bioAffinity Technologies Warrant or give up 23.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Dupont De Nemours vs. bioAffinity Technologies Warra
Performance |
| Timeline |
| Dupont De Nemours |
| BioAffinity Technologies |
Dupont De and BioAffinity Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and BioAffinity Technologies
The main advantage of trading using opposite Dupont De and BioAffinity Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, BioAffinity Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies will offset losses from the drop in BioAffinity Technologies' long position.| Dupont De vs. Direxion Daily FTSE | Dupont De vs. Collegium Pharmaceutical | Dupont De vs. KKR Co LP | Dupont De vs. iShares Dividend and |
| BioAffinity Technologies vs. bioAffinity Technologies, | BioAffinity Technologies vs. AAP Inc | BioAffinity Technologies vs. Discount Print USA | BioAffinity Technologies vs. HUMANA INC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |